Oncologia

NICE issues guidance on the use of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma

NICE has issued guidance on the use of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma, a type of cancerous brain tumour.
Approfondisci

 http://www.nice.org.uk/page.aspx?o=438338...

National Institute for Health and Clinical Excellence